P

PolyProx Therapeutics Ltd

9 employees

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2019

Funding rounds raised

Total raised

$4.4M

from 4 investors over 4 rounds

P

PolyProx Therapeutics Ltd raised $4.4M on April 30, 2019

Investors: Cambridge Innovation Capital plc, Cambridge Enterprise, Future Planet Capital and Parkwalk Advisors

FAQ